Skip to main content

Advertisement

ADVERTISEMENT

Volume 24 - Issue 7 - July 2012

Feature

Original Contribution
06/29/2012

Sajid Dhakam, MD1, Asif Jafferani, MBBS2, Hafeez Ahmed, MBBS1, Nasir Rahman, MBBS1, Ambreen Gowani, BScN1

Sajid Dhakam, MD1, Asif Jafferani, MB...
Abstract: Background. The advent of drug-eluting balloons (DEBs) is a promising development for coronary revascularization procedures, especially for in-stent restenosis (ISR). This study aims to highlight our experience with DEBs in the...
Abstract: Background. The advent of drug-eluting balloons (DEBs) is a promising development for coronary revascularization procedures, especially for in-stent restenosis (ISR). This study aims to highlight our experience with DEBs in the...
Abstract: Background. The advent...
06/29/2012
Journal of Invasive Cardiology
Original Contribution
06/29/2012

Dale R. Tavris, MD, MPH1, Yongfei Wang, MS2, Samantha Jacobs, BS1, Beverly Gallauresi, MPH, RN1, Jeptha Curtis, MD2, John Messenger, MD3, Frederic S. Resnic, MD, MSc4, Susan Fitzgerald, MS, RN5

Dale R. Tavris, MD, MPH1, Yongfei Wan...
Abstract: Background. Previous research found at least one vascular closure device (VCD) to be associated with excess vascular complications, compared to manual compression (MC) controls, following cardiac catheterization. Since that time,...
Abstract: Background. Previous research found at least one vascular closure device (VCD) to be associated with excess vascular complications, compared to manual compression (MC) controls, following cardiac catheterization. Since that time,...
Abstract: Background. Previous...
06/29/2012
Journal of Invasive Cardiology
Original Contribution
06/29/2012

Mauro Maioli, MD1, Uwe Zeymer, MD2, Arnoud W.J. van ’t Hof, MD3, C. Michael Gibson, MD4, Dariusz Dudek, MD5, Francesco Bellandi, MD1, Marko Noc, MD6, Gioel Gabrio Secco, MD7, Simona Zorman, MD6, H. Mesquita Gabriel, MD8, Ayse Emre, MD9, Donald Cutlip, MD10, Tomasz Rakowski, MD5, Maryann Gyongyosi, MD11, Kurt Huber, MD12, Giuseppe De Luca, MD13, on behalf of the EGYPT Cooperation

Mauro Maioli, MD1, Uwe Zeymer, MD2, A...
Abstract: Background. Despite optimal epicardial recanalization, primary angioplasty for ST-elevation myocardial infarction (STEMI) is still associated with suboptimal reperfusion in a relatively large proportion of patients. The aim of the...
Abstract: Background. Despite optimal epicardial recanalization, primary angioplasty for ST-elevation myocardial infarction (STEMI) is still associated with suboptimal reperfusion in a relatively large proportion of patients. The aim of the...
Abstract: Background. Despite...
06/29/2012
Journal of Invasive Cardiology
Original Contribution
06/29/2012

Armando Pérez de Prado, MD, Carlos Cuellas, MD, Alejandro Diego, MD, Jose M. Gonzalo-Orden, DVM, PhD, Claudia Pérez-Martínez, DVM, PhD, Marta Regueiro, DVM, PhD, Antonio de Miguel, MD, Jose M. Ajenjo, DVM, Beatriz Martínez-Fernández, DVM, Jose R. Altonaga, DVM, PhD, Felipe Fernández-Vázquez, MD, PhD

Armando Pérez de Prado, MD, Carlos C...
Abstract: Background and Objectives. Incomplete re-endothelialization of stents can be revealed as paradoxical vasoconstriction with endothelium-dependent vasodilators. As no consensus exists about the best method or agent, our objective is...
Abstract: Background and Objectives. Incomplete re-endothelialization of stents can be revealed as paradoxical vasoconstriction with endothelium-dependent vasodilators. As no consensus exists about the best method or agent, our objective is...
Abstract: Background and...
06/29/2012
Journal of Invasive Cardiology
Original Contribution
06/29/2012

Michael S. Lee, MD*1, Kyung Woo Park, MD*2, Si-Hyuck Kang, MD2, Imad Sheiban, MD3, Ehtisham Mahmud, MD8, Khalid Bin Thani, MD8, Richard Cheng, MD1, Jang-Hyun Cho, MD5, Dong-Kyu Jin, MD7, Hyeon-Cheol Gwon, MD6, In-Ho Chae, MD4, Joseph Aragon, MD9, Kyle Gillis, BS9, Gregg W. Stone, MD10, Hyo-Soo Kim, MD2

Michael S. Lee, MD*1, Kyung Woo Park,...
Abstract: Objective. The aim of this study was to assess the clinical outcomes of percutaneous coronary intervention (PCI) with everolimus-eluting stents (EES) for the treatment of unprotected left main coronary artery (ULMCA) disease....
Abstract: Objective. The aim of this study was to assess the clinical outcomes of percutaneous coronary intervention (PCI) with everolimus-eluting stents (EES) for the treatment of unprotected left main coronary artery (ULMCA) disease....
Abstract: Objective. The aim of...
06/29/2012
Journal of Invasive Cardiology
Original Contribution
06/29/2012

Louis H. Miller, MD, Bora Toklu, MD, Judah Rauch, MD, Jeffrey D. Lorin, MD, Iryna Lobach, PhD, Steven P. Sedlis, MD

Louis H. Miller, MD, Bora Toklu, MD, ...
Abstract: Background. Randomized trials using measurement of fractional flow reserve (FFR) to guide percutaneous coronary intervention (PCI) have demonstrated both safety and efficacy with regard to cardiac events. Real-world, long-term...
Abstract: Background. Randomized trials using measurement of fractional flow reserve (FFR) to guide percutaneous coronary intervention (PCI) have demonstrated both safety and efficacy with regard to cardiac events. Real-world, long-term...
Abstract: Background. Randomized...
06/29/2012
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement